UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: Mechanisms and therapeutic opportunities

Journal of molecular and cellular cardiology, 2011-04, Vol.50 (4), p.613-620

2011

Volltextzugriff (PDF)

Piezo2 is not an indispensable mechanosensor in murine cardiomyocytes

Scientific reports, 2022-05, Vol.12 (1), p.8193-8193, Article 8193

2022

Volltextzugriff (PDF)

Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

EMBO molecular medicine, 2019-12, Vol.11 (12), p.e11115-n/a

2019

Volltextzugriff (PDF)

The W101C KCNJ5 Mutation Induces Slower Pacing by Constitutively Active GIRK Channels in hiPSC-Derived Cardiomyocytes

International journal of molecular sciences, 2023-10, Vol.24 (20), p.15290

2023

Volltextzugriff (PDF)

Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice

Nature communications, 2014-12, Vol.5 (1), p.5515, Article 5515

2014

Volltextzugriff (PDF)

Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue

Journal of molecular and cellular cardiology, 2016-08, Vol.97, p.82-92

2016

Volltextzugriff (PDF)

Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A)

Stem cell research, 2024-08, Vol.78, p.103446, Article 103446

2024

Volltextzugriff (PDF)

Endothelin‐1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy–Induced Pluripotent Stem Cell–Derived Cardiomyocytes

Journal of the American Heart Association, 2014-11, Vol.3 (6), p.e001263-n/a

2014

Volltextzugriff (PDF)

Nonsense-Mediated mRNA Decay and Ubiquitin–Proteasome System Regulate Cardiac Myosin-Binding Protein C Mutant Levels in Cardiomyopathic Mice

Circulation research, 2009-07, Vol.105 (3), p.239-248

2009

Volltextzugriff (PDF)

Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes

Molecular therapy. Nucleic acids, 2017-06, Vol.7 (C), p.475-486

2017

Volltextzugriff (PDF)

MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction

Pflügers Archiv, 2014-02, Vol.466 (2), p.215-223

2014

Volltextzugriff (PDF)

Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy

Journal of cardiac failure, 2016-10, Vol.22 (10), p.845-850

2016

Volltextzugriff (PDF)

Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

EMBO molecular medicine, 2022-08, Vol.14 (8), p.e16423-n/a

2022

Volltextzugriff (PDF)

Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms

Cardiovascular research, 2010-01, Vol.85 (2), p.357-366

2010

Volltextzugriff (PDF)

Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue

Frontiers in physiology, 2019-03, Vol.10, p.239-239

2019

Volltextzugriff (PDF)

Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy

Stem cell research, 2021-08, Vol.55, p.102489-102489, Article 102489

2021

Volltextzugriff (PDF)

ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes

Cells (Basel, Switzerland), 2022-09, Vol.11 (17), p.2745

2022

Volltextzugriff (PDF)

Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice

Journal of muscle research and cell motility, 2012-05, Vol.33 (1), p.5-15

2012

Volltextzugriff (PDF)

Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology

Gene, 2015-12, Vol.573 (2), p.188-197

2015

Volltextzugriff (PDF)

Gene therapy strategies in the treatment of hypertrophic cardiomyopathy

Pflügers Archiv, 2019-05, Vol.471 (5), p.807-815

2019

Volltextzugriff (PDF)

Effects of Chronic Atrial Fibrillation on Active and Passive Force Generation in Human Atrial Myofibrils

Circulation research, 2010-07, Vol.107 (1), p.144-152

2010

Volltextzugriff (PDF)

Repair of Mybpc3 mRNA by 5′-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy

Molecular therapy. Nucleic acids, 2013-07, Vol.2 (7), p.e102-e102, Article e102

2013

Volltextzugriff (PDF)

BSE-associated prion-amyloid cardiomyopathy in primates

Emerging infectious diseases, 2013-06, Vol.19 (6), p.985-988

2013

Volltextzugriff (PDF)

Local Chromatin Mobility is Independent of Transcriptional Activity

Cell cycle (Georgetown, Tex.), 2006-09, Vol.5 (17), p.1989-1995

2006

Volltextzugriff (PDF)

Differentiation of cardiomyocytes and generation of human engineered heart tissue

Nature protocols, 2017-06, Vol.12 (6), p.1177-1197

2017

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(63)

Sprache

Englisch
(63)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(44)
Humans
(23)
Animals
(21)
Mutation
(15)
Cell Biology
(14)
Cardiomyopathy
(13)
Cardiac & Cardiovascular Systems
(11)
Cardiovascular System & Cardiology
(11)
Male
(11)
Carrier Proteins - Genetics
(10)
Cardiomyocytes
(9)
Carrier Proteins - Metabolism
(9)
Mice
(9)
Cardiomyopathy, Hypertrophic - Genetics
(8)
Female
(8)
Hypertrophic Cardiomyopathy
(8)
Gene Expression
(7)
Hypertrophy
(7)
Medicine, Research & Experimental
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: Mechanisms and therapeutic opportunities

Piezo2 is not an indispensable mechanosensor in murine cardiomyocytes

Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

The W101C KCNJ5 Mutation Induces Slower Pacing by Constitutively Active GIRK Channels in hiPSC-Derived Cardiomyocytes

Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice

Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue

Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A)

Endothelin‐1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy–Induced Pluripotent Stem Cell–Derived Cardiomyocytes

Nonsense-Mediated mRNA Decay and Ubiquitin–Proteasome System Regulate Cardiac Myosin-Binding Protein C Mutant Levels in Cardiomyopathic Mice

Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes

MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction

Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy

Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms

Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue

Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy

ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes

Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice

Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology

Gene therapy strategies in the treatment of hypertrophic cardiomyopathy

Effects of Chronic Atrial Fibrillation on Active and Passive Force Generation in Human Atrial Myofibrils

Repair of Mybpc3 mRNA by 5′-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy

BSE-associated prion-amyloid cardiomyopathy in primates

Local Chromatin Mobility is Independent of Transcriptional Activity

Differentiation of cardiomyocytes and generation of human engineered heart tissue

Suchergebnisse filtern